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Background: 18F-Sodium fluoride (18FNaF) is a promising biomarker of disease activity in aortic stenosis. We aimed to compare 18FNaF uptake 
with histology of the aortic valve and assess whether it predicts disease progression.
methods: 20 patients with aortic valve disease underwent PET/CT scanning using 18FNaF and 18FFDG. Echocardiography and CT calcium scoring 
of the valve was performed at baseline and 1 year. A further 7 patients underwent 18FNaF PET/CT prior to aortic valve replacement. Activity was 
compared to excised valve tissue using immunohistochemistry for osteocalcin and alkaline phosphatase.
results: Over 1 year aortic valve calcification increased (469±479 vs 580±576 p<0.01) in patients with a range of disease severity (6 sclerosis; 
5 mild, 7 moderate, 2 severe stenosis). 18FNaF uptake correlated with disease progression: both in terms of the calcium score (r2=0.44 p<0.01) 
and aortic valve area (r2=0.24 P=0.03). When 18FNaF overlying existing calcium on the CT was excluded, the correlation improved further (r2= 0.64 
p<0.01). There were no associations between 18FFDG uptake and CT or echo measures of disease progression (r2=0.02 p=0.55). There was a good 
correlation between in vivo 18FNaF uptake and both alkaline phosphatase (n=7; r2=0.79 P<0.01) and osteocalcin staining (n=5; r2=0.43 P=0.22) 
of the excised tissue.
conclusion: 18F-NaF is a marker of active calcification and disease progression in patients with aortic stenosis with major potential for assessing 
novel therapeutic strategies.
